CLINICAL_TRIALS
trial_result
· 2022-05-11
Clinical Trial Update: Ivermectin Nasal Drops in Post COVID-19 Parosmia [Phase 2]
Summary
Phase 2 clinical trial evaluating ivermectin nasal drops for post-COVID-19 parosmia is ongoing with unknown status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Menoufia University | Conditions: Parosmia | Phase 2 | Status: UNKNOWN